Alarmins: Feel the stress

Journal of Immunology

Volumn 198, Issue 4, 2017, Pages 1395-1402

  Rider, Peleg ^a   Voronov, Elena ^a   Dinarello, Charles A ^b   Apte, Ron N ^a   Cohen, Idan ^c  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b UNIVERSITY OF COLORADO   (United States)

^c Nahariya Hospital Israel   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALARMIN; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 16; INTERLEUKIN 1ALPHA; INTERLEUKIN 33; IL1A PROTEIN, HUMAN; IL33 PROTEIN, HUMAN;

CARBOXY TERMINAL SEQUENCE; CELLULAR DISTRIBUTION; HUMAN; MOLECULAR RECOGNITION; NONHUMAN; PHYSIOLOGICAL PROCESS; PHYSIOLOGICAL STRESS; PROTEIN CLEAVAGE; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; IMMUNOLOGY; INFLAMMATION; METABOLISM; MOUSE; PHYSIOLOGY;

ALARMINS; ANIMALS; HMGB1 PROTEIN; HUMANS; INFLAMMATION; INTERLEUKIN-16; INTERLEUKIN-1ALPHA; INTERLEUKIN-33; MICE; PROTEIN PROCESSING, POST-TRANSLATIONAL; STRESS, PHYSIOLOGICAL;

EID: 85014675862     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1601342     Document Type: Review

References (114)

1. Murray, R. Z., and J. L. Stow. 2014. Cytokine secretion in macrophages: SNAREs, Rabs, and membrane trafficking. Front. Immunol. 5: 538.
2. Rubartelli, A., M. T. Lotze, E. Latz, and A. Manfredi. 2013. Mechanisms of sterile inflammation. Front. Immunol. 4: 398.
3. Chen, G. Y., and G. Nunẽz. 2010. Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 10: 826-837.
4. Matzinger, P. 1994. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12: 991-1045.
5. Matzinger, P. 2002. The danger model: a renewed sense of self. Science 296: 301-305.
6. Piccinini, A. M., and K. S. Midwood. 2010. DAMPening inflammation by modulating TLR signalling. Mediators Inflamm. Available at: https://www. hindawi.com/journals/mi/2010/672395/.
7. Cohen, I., P. Rider, Y. Carmi, A. Braiman, S. Dotan, M. R. White, E. Voronov, M. U. Martin, C. A. Dinarello, and R. N. Apte. 2010. Differential release of chromatin-bound IL-1alpha discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammation. Proc. Natl. Acad. Sci. USA 107: 2574-2579.
8. Carriere, V., L. Roussel, N. Ortega, D. A. Lacorre, L. Americh, L. Aguilar, G. Bouche, and J. P. Girard. 2007. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc. Natl. Acad. Sci. USA 104: 282-287.
9. Moussion, C., N. Ortega, and J. P. Girard. 2008. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'? PLoS One 3: e3331.
10. Scaffidi, P., T. Misteli, and M. E. Bianchi. 2002. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418: 191-195.
11. Cruikshank, W., and F. Little. 2008. Interleukin-16: the ins and outs of regulating T-cell activation. Crit. Rev. Immunol. 28: 467-483.
12. Zhang, Y., H. Kornfeld, W. W. Cruikshank, S. Kim, C. C. Reardon, and D. M. Center. 2001. Nuclear translocation of the N-terminal prodomain of interleukin-16. J. Biol. Chem. 276: 1299-1303.
13. Wilson, K. C., W. W. Cruikshank, D. M. Center, and Y. Zhang. 2002. Prointerleukin-16 contains a functional CcN motif that regulates nuclear localization. Biochemistry 41: 14306-14312.
14. Center, D. M., W. W. Cruikshank, and Y. Zhang. 2004. Nuclear pro-IL-16 regulation of T cell proliferation: p27(KIP1)-dependent G0/G1 arrest mediated by inhibition of Skp2 transcription. J. Immunol. 172: 1654-1660.
15. Bianchi, M. E., and A. Agresti. 2005. HMG proteins: dynamic players in gene regulation and differentiation. Curr. Opin. Genet. Dev. 15: 496-506.
16. Roussel, L., M. Erard, C. Cayrol, and J. P. Girard. 2008. Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A-H2B acidic pocket. EMBO Rep. 9: 1006-1012.
17. Afonina, I. S., C. Muller, S. J. Martin, and R. Beyaert. 2015. Proteolytic processing of interleukin-1 family cytokines: variations on a common theme. Immunity 42: 991-1004.
18. Luheshi, N. M., B. W. McColl, and D. Brough. 2009. Nuclear retention of IL-1 alpha by necrotic cells: a mechanism to dampen sterile inflammation. Eur. J. Immunol. 39: 2973-2980.
19. Bessa, J., C. A. Meyer, M. C. de Vera Mudry, S. Schlicht, S. H. Smith, A. Iglesias, and J. Cote-Sierra. 2014. Altered subcellular localization of IL-33 leads to nonresolving lethal inflammation. J. Autoimmun. 55: 33-41.
20. Zheng, Y., M. Humphry, J. J. Maguire, M. R. Bennett, and M. C. Clarke. 2013. Intracellular interleukin-1 receptor 2 binding prevents cleavage and activity of interleukin-1a, controlling necrosis-induced sterile inflammation. Immunity 38: 285-295.
21. Lefrançais, E., S. Roga, V. Gautier, A. Gonzalez-de-Peredo, B. Monsarrat, J. P. Girard, and C. Cayrol. 2012. IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proc. Natl. Acad. Sci. USA 109: 1673-1678.
22. Lefrançais, E., A. Duval, E. Mirey, S. Roga, E. Espinosa, C. Cayrol, and J. P. Girard. 2014. Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells. Proc. Natl. Acad. Sci. USA 111: 15502-15507.
23. Cohen, I., P. Rider, E. Vornov, M. Tomas, C. Tudor, M. Wegner, L. Brondani, M. Freudenberg, G. Mittler, E. Ferrando-May, et al. 2016. Corrigendum: IL-1a is a DNA damage sensor linking genotoxic stress signaling to sterile inflammation and innate immunity. Sci. Rep. 6: 19100.
24. Rider, P., Y. Carmi, E. Voronov, and R. N. Apte. 2013. Interleukin-1a. Semin. Immunol. 25: 430-438.
25. Muller, S., L. Ronfani, and M. E. Bianchi. 2004. Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function. J. Intern. Med. 255: 332-343.
26. Lotze, M. T., and K. J. Tracey. 2005. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 5: 331-342.
27. Pauwels, N. S., K. R. Bracke, L. L. Dupont, G. R. Van Pottelberge, S. Provoost, T. Vanden Berghe, P. Vandenabeele, B. N. Lambrecht, G. F. Joos, and G. G. Brusselle. 2011. Role of IL-1a and the Nlrp3/caspase-1/IL-1b axis in cigarette smoke-induced pulmonary inflammation and COPD. Eur. Respir. J. 38: 1019-1028.
28. Botelho, F. M., C. M. Bauer, D. Finch, J. K. Nikota, C. C. Zavitz, A. Kelly, K. N. Lambert, S. Piper, M. L. Foster, J. J. Goldring, et al. 2011. IL-1a/IL-1R1 expression in chronic obstructive pulmonary disease and mechanistic relevance to smoke-induced neutrophilia in mice. PLoS One 6: e28457.
29. Lee, P. Y., Y. Kumagai, Y. Xu, Y. Li, T. Barker, C. Liu, E. S. Sobel, O. Takeuchi, S. Akira, M. Satoh, and W. H. Reeves. 2011. IL-1a modulates neutrophil recruitment in chronic inflammation induced by hydrocarbon oil. J. Immunol. 186: 1747-1754.
30. Kearley, J., J. S. Silver, C. Sanden, Z. Liu, A. A. Berlin, N. White, M. Mori, T. H. Pham, C. K. Ward, G. J. Criner, et al. 2015. Cigarette smoke silences innate lymphoid cell function and facilitates an exacerbated type I interleukin-33-dependent response to infection. Immunity 42: 566-579.
31. Fang, H., B. Ang, X. Xu, X. Huang, Y. Wu, Y. Sun, W. Wang, N. Li, X. Cao, and T. Wan. 2014. TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells. Cell. Mol. Immunol. 11: 150-159.
32. Wellen, K. E., and G. S. Hotamisligil. 2005. Inflammation, stress, and diabetes. J. Clin. Invest. 115: 1111-1119.
33. Okin, D., and R. Medzhitov. 2016. The effect of sustained inflammation on hepatic mevalonate pathway results in hyperglycemia. Cell 165: 343-356.
34. Freigang, S., F. Ampenberger, A. Weiss, T. D. Kanneganti, Y. Iwakura, M. Hersberger, and M. Kopf. 2013. Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1a and sterile vascular inflammation in atherosclerosis. Nat. Immunol. 14: 1045-1053.
35. Rosa, J. S., R. L. Flores, S. R. Oliver, A. M. Pontello, F. P. Zaldivar, and P. R. Galassetti. 2008. Sustained IL-1alpha, IL-4, and IL-6 elevations following correction of hyperglycemia in children with type 1 diabetes mellitus. Pediatr. Diabetes 9: 9-16.
36. Mirhafez, S. R., A. Pasdar, A. Avan, H. Esmaily, A. Moezzi, M. Mohebati, Z. Meshkat, H. Mehrad-Majd, S. Eslami, H. R. Rahimi, et al. 2015. Cytokine and growth factor profiling in patients with the metabolic syndrome. Br. J. Nutr. 113: 1911-1919.
37. Um, J. Y., H. K. Rim, S. J. Kim, H. L. Kim, and S. H. Hong. 2011. Functional polymorphism of IL-1 alpha and its potential role in obesity in humans and mice. PLoS One 6: e29524.
38. Janik, J. E., B. D. Curti, R. V. Considine, H. C. Rager, G. C. Powers, W. G. Alvord, J. W. Smith, II, B. L. Gause, and W. C. Kopp. 1997. Interleukin 1 alpha increases serum leptin concentrations in humans. J. Clin. Endocrinol. Metab. 82: 3084-3086.
39. Kumar, S., H. Kishimoto, H. L. Chua, S. Badve, K. D. Miller, R. M. Bigsby, and H. Nakshatri. 2003. Interleukin-1 alpha promotes tumor growth and cachexia in MCF-7 xenograft model of breast cancer. Am. J. Pathol. 163: 2531-2541.
40. Karakasilioti, I., I. Kamileri, G. Chatzinikolaou, T. Kosteas, E. Vergadi, A. R. Robinson, I. Tsamardinos, T. A. Rozgaja, S. Siakouli, C. Tsatsanis, et al. 2013. DNA damage triggers a chronic autoinflammatory response, leading to fat depletion in NER progeria. Cell Metab. 18: 403-415.
41. Calogero, S., F. Grassi, A. Aguzzi, T. Voigtländer, P. Ferrier, S. Ferrari, and M. E. Bianchi. 1999. The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice. Nat. Genet. 22: 276-280.
42. Tang, D., R. Kang, K. M. Livesey, G. Kroemer, T. R. Billiar, B. Van Houten, H. J. Zeh, III, and M. T. Lotze. 2011. High-mobility group box 1 is essential for mitochondrial quality control. Cell Metab. 13: 701-711.
43. Gunasekaran, M. K., W. Viranaicken, A. C. Girard, F. Festy, M. Cesari, R. Roche, and L. Hoareau. 2013. Inflammation triggers high mobility group box 1 (HMGB1) secretion in adipose tissue, a potential link to obesity. Cytokine 64: 103-111.
44. Guzmán-Ruiz, R., F. Ortega, A. Rodŕguez, R. Vázquez-Martnez, A. Daz-Ruiz, S. Garcia-Navarro, M. Giralt, A. Garcia-Rios, D. Cobo-Padilla, F. J. Tinahones, et al. 2014. Alarmin high-mobility group B1 (HMGB1) is regulated in human adipocytes in insulin resistance and influences insulin secretion in b-cells. Int. J. Obes. 38: 1545-1554.
45. Arrigo, T., V. Chirico, V. Salpietro, C. Munafò, V. Ferraù, E. Gitto, A. Lacquaniti, and C. Salpietro. 2013. High-mobility group protein B1: a new biomarker of metabolic syndrome in obese children. Eur. J. Endocrinol. 168: 631-638.
46. Fong, Y., L. L. Moldawer, M. Marano, H. Wei, A. Barber, K. Manogue, K. J. Tracey, G. Kuo, D. A. Fischman, A. Cerami, et al. 1989. Cachectin/TNF or IL-1 alpha induces cachexia with redistribution of body proteins. Am. J. Physiol. 256: R659-R665.
47. Montes, V. N., S. Subramanian, L. Goodspeed, S. A. Wang, M. Omer, A. Bobik, K. Teshigawara, M. Nishibori, and A. Chait. 2015. Anti-HMGB1 antibody reduces weight gain in mice fed a high-fat diet. Nutr. Diabetes 5: e161.
48. Hong, D. S., D. Hui, E. Bruera, F. Janku, A. Naing, G. S. Falchook, S. Piha-Paul, J. J. Wheler, S. Fu, A. M. Tsimberidou, et al. 2014. MABp1, a first-in-class true human antibody targeting interleukin-1a in refractory cancers: an open-label, phase 1 dose-escalation and expansion study. Lancet Oncol. 15: 656-666.
49. Dinarello, C. A. 2014. Interleukin-1a neutralisation in patients with cancer. Lancet Oncol. 15: 552-553.
50. Cooke, M. S., M. D. Evans, M. Dizdaroglu, and J. Lunec. 2003. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J. 17: 1195-1214.
51. Wiseman, H., and B. Halliwell. 1996. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem. J. 313: 17-29.
52. Federico, A., F. Morgillo, C. Tuccillo, F. Ciardiello, and C. Loguercio. 2007. Chronic inflammation and oxidative stress in human carcinogenesis. Int. J. Cancer 121: 2381-2386.
53. Bianchi, M. E. 2009. HMGB1 loves company. J. Leukoc. Biol. 86: 573-576.
54. Yu, Y., D. Tang, and R. Kang. 2015. Oxidative stress-mediated HMGB1 biology. Front. Physiol. 6: 93.
55. Liu, A., H. Fang, O. Dirsch, H. Jin, and U. Dahmen. 2012. Oxidation of HMGB1 causes attenuation of its pro-inflammatory activity and occurs during liver ischemia and reperfusion. PLoS One 7: e35379.
56. Urbonaviciute, V., S. Meister, B. G. Furnrohr, B. Frey, E. Guckel, G. Schett, M. Herrmann, and R. E. Voll. 2009. Oxidation of the alarmin high-mobility group box 1 protein (HMGB1) during apoptosis. Autoimmunity 42: 305-307.
57. Kazama, H., J. E. Ricci, J. M. Herndon, G. Hoppe, D. R. Green, and T. A. Ferguson. 2008. Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity 29: 21-32.
58. Peter, M. E. 2008. ROS eliminate danger. Immunity 29: 1-2.
59. Johnson, K. E., B. C. Wulff, T. M. Oberyszyn, and T. A. Wilgus. 2013. Ultraviolet light exposure stimulates HMGB1 release by keratinocytes. Arch. Dermatol. Res. 305: 805-815.
60. Han, S. J., H. J. Min, S. C. Yoon, E. A. Ko, S. J. Park, J. H. Yoon, J. S. Shin, and K. Y. Seo. 2015. HMGB1 in the pathogenesis of ultraviolet-induced ocular surface inflammation. Cell Death Dis. 6: e1863.
61. Bald, T., T. Quast, J. Landsberg, M. Rogava, N. Glodde, D. Lopez-Ramos, J. Kohlmeyer, S. Riesenberg, D. van den Boorn-Konijnenberg, C. Hömig-Hölzel, et al. 2014. Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma. Nature 507: 109-113.
62. Cohen, E. S., I. C. Scott, J. B. Majithiya, L. Rapley, B. P. Kemp, E. England, D. G. Rees, C. L. Overed-Sayer, J. Woods, N. J. Bond, et al. 2015. Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation. Nat. Commun. 6: 8327.
63. McCarthy, D. A., R. R. Clark, T. R. Bartling, M. Trebak, and J. A. Melendez. 2013. Redox control of the senescence regulator interleukin-1a and the secretory phenotype. J. Biol. Chem. 288: 32149-32159.
64. Kupper, T. S. 1988. Interleukin 1 and other human keratinocyte cytokines: molecular and functional characterization. Adv. Dermatol. 3: 293-307.
65. Nozaki, S., J. S. Abrams, M. K. Pearce, and D. N. Sauder. 1991. Augmentation of granulocyte/macrophage colony-stimulating factor expression by ultraviolet irradiation is mediated by interleukin 1 in Pam 212 keratinocytes. J. Invest. Dermatol. 97: 10-14.
66. McCarthy, D. A., A. Ranganathan, S. Subbaram, N. L. Flaherty, N. Patel, M. Trebak, N. Hempel, and J. A. Melendez. 2013. Redox-control of the alarmin, Interleukin-1a. Redox Biol. 1: 218-225.
67. Manzer, R., C. A. Dinarello, G. McConville, and R. J. Mason. 2008. Ozone exposure of macrophages induces an alveolar epithelial chemokine response through IL-1alpha. Am. J. Respir. Cell Mol. Biol. 38: 318-323.
68. Bagaitkar, J., N. K. Pech, S. Ivanov, A. Austin, M. Y. Zeng, S. Pallat, G. Huang, G. J. Randolph, and M. C. Dinauer. 2015. NADPH oxidase controls neutrophilic response to sterile inflammation in mice by regulating the IL-1a/G-CSF axis. Blood 126: 2724-2733.
69. Chandel, N. S., D. S. McClintock, C. E. Feliciano, T. M. Wood, J. A. Melendez, A. M. Rodriguez, and P. T. Schumacker. 2000. Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing. J. Biol. Chem. 275: 25130-25138.
70. Rider, P., I. Kaplanov, M. Romzova, L. Bernardis, A. Braiman, E. Voronov, and R. N. Apte. 2012. The transcription of the alarmin cytokine interleukin-1 alpha is controlled by hypoxia inducible factors 1 and 2 alpha in hypoxic cells. Front. Immunol. 3: 290.
71. Gardella, S., C. Andrei, D. Ferrera, L. V. Lotti, M. R. Torrisi, M. E. Bianchi, and A. Rubartelli. 2002. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep. 3: 995-1001.
72. Carta, S., R. Lavieri, and A. Rubartelli. 2013. Different members of the IL-1 family come out in different ways: DAMPs vs. cytokines? Front. Immunol. 4: 123.
73. Oberle, C., and C. Blattner. 2010. Regulation of the DNA damage response to DSBs by post-translational modifications. Curr. Genomics 11: 184-198.
74. Appella, E., and C. W. Anderson. 2001. Post-translational modifications and activation of p53 by genotoxic stresses. Eur. J. Biochem. 268: 2764-2772.
75. Vucic, D., V. M. Dixit, and I. E. Wertz. 2011. Ubiquitylation in apoptosis: a posttranslational modification at the edge of life and death. Nat. Rev. Mol. Cell Biol. 12: 439-452.
76. Xu, Y. M., D. Y. Huang, J. F. Chiu, and A. T. Lau. 2012. Post-translational modification of human heat shock factors and their functions: a recent update by proteomic approach. J. Proteome Res. 11: 2625-2634.
77. Ryan, B. J., A. Nissim, and P. G. Winyard. 2014. Oxidative post-translational modifications and their involvement in the pathogenesis of autoimmune diseases. Redox Biol. 2: 715-724.
78. Kumar, G. K., and N. R. Prabhakar. 2008. Post-translational modification of proteins during intermittent hypoxia. Respir. Physiol. Neurobiol. 164: 272-276.
79. Ohn, T., and P. Anderson. 2010. The role of posttranslational modifications in the assembly of stress granules. Wiley Interdiscip. Rev. RNA 1: 486-493.
80. Stone, M. J., S. Chuang, X. Hou, M. Shoham, and J. Z. Zhu. 2009. Tyrosine sulfation: an increasingly recognised post-translational modification of secreted proteins. N. Biotechnol. 25: 299-317.
81. Fabbro, M., and B. R. Henderson. 2003. Regulation of tumor suppressors by nuclear-cytoplasmic shuttling. Exp. Cell Res. 282: 59-69.
82. Maier, J. A., M. Statuto, and G. Ragnotti. 1994. Endogenous interleukin 1 alpha must be transported to the nucleus to exert its activity in human endothelial cells. Mol. Cell. Biol. 14: 1845-1851.
83. Stevenson, F. T., J. Turck, R. M. Locksley, and D. H. Lovett. 1997. The N-terminal propiece of interleukin 1 alpha is a transforming nuclear oncoprotein. Proc. Natl. Acad. Sci. USA 94: 508-513.
84. McMahon, G. A., S. Garfinkel, I. Prudovsky, X. Hu, and T. Maciag. 1997. Intracellular precursor interleukin (IL)-1alpha, but not mature IL-1alpha, is able to regulate human endothelial cell migration in vitro. J. Biol. Chem. 272: 28202-28205.
85. Pollock, A. S., J. Turck, and D. H. Lovett. 2003. The prodomain of interleukin 1alpha interacts with elements of the RNA processing apparatus and induces apoptosis in malignant cells. FASEB J. 17: 203-213.
86. Bonaldi, T., F. Talamo, P. Scaffidi, D. Ferrera, A. Porto, A. Bachi, A. Rubartelli, A. Agresti, and M. E. Bianchi. 2003. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J. 22: 5551-5560.
87. Lu, B., D. J. Antoine, K. Kwan, P. Lundbäck, H. Wähämaa, H. Schierbeck, M. Robinson, M. A. Van Zoelen, H. Yang, J. Li, et al. 2014. JAK/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation. Proc. Natl. Acad. Sci. USA 111: 3068-3073.
88. Dudley, A. C., D. Thomas, J. Best, and A. Jenkins. 2004. The STATs in cell stresstype responses. Cell Commun. Signal. 2: 8.
89. Hwang, J. S., H. S. Choi, S. A. Ham, T. Yoo, W. J. Lee, K. S. Paek, and H. G. Seo. 2015. Deacetylation-mediated interaction of SIRT1-HMGB1 improves survival in a mouse model of endotoxemia. Sci. Rep. 5: 15971.
90. Lee, H., M. Park, N. Shin, G. Kim, Y. G. Kim, J. S. Shin, and H. Kim. 2012. High mobility group box-1 is phosphorylated by protein kinase C zeta and secreted in colon cancer cells. Biochem. Biophys. Res. Commun. 424: 321-326.
91. Youn, J. H., and J. S. Shin. 2006. Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion. J. Immunol. 177: 7889-7897.
92. Ito, I., J. Fukazawa, and M. Yoshida. 2007. Post-translational methylation of high mobility group box 1 (HMGB1) causes its cytoplasmic localization in neutrophils. J. Biol. Chem. 282: 16336-16344.
93. Wu, F., Z. H. Zhao, S. T. Ding, H. H. Wu, and J. J. Lu. 2013. High mobility group box 1 protein is methylated and transported to cytoplasm in clear cell renal cell carcinoma. Asian Pac. J. Cancer Prev. 14: 5789-5795.
94. Yang, Z., L. Li, L. Chen, W. Yuan, L. Dong, Y. Zhang, H. Wu, and C. Wang. 2014. PARP-1 mediates LPS-induced HMGB1 release by macrophages through regulation of HMGB1 acetylation. J. Immunol. 193: 6114-6123.
95. Kim, Y. H., M. S. Kwak, J. B. Park, S. A. Lee, J. E. Choi, H. S. Cho, and J. S. Shin. 2016. N-linked glycosylation plays a crucial role in the secretion of HMGB1. J. Cell Sci. 129: 29-38.
96. Laurence, A., E. Astoul, S. Hanrahan, N. Totty, and D. Cantrell. 2004. Identification of pro-interleukin 16 as a novel target of MAP kinases in activated T lymphocytes. Eur. J. Immunol. 34: 587-597.
97. Beuscher, H. U., M. W. Nickells, and H. R. Colten. 1988. The precursor of interleukin-1 alpha is phosphorylated at residue serine 90. J. Biol. Chem. 263: 4023-4028.
98. Kobayashi, Y., E. Appella, M. Yamada, T. D. Copeland, J. J. Oppenheim, and K. Matsushima. 1988. Phosphorylation of intracellular precursors of human IL-1. J. Immunol. 140: 2279-2287.
99. Stevenson, F. T., S. L. Bursten, C. Fanton, R. M. Locksley, and D. H. Lovett. 1993. The 31-kDa precursor of interleukin 1 alpha is myristoylated on specific lysines within the 16-kDa N-terminal propiece. Proc. Natl. Acad. Sci. USA 90: 7245-7249.
100. Jiang, H., S. Khan, Y. Wang, G. Charron, B. He, C. Sebastian, J. Du, R. Kim, E. Ge, R. Mostoslavsky, et al. 2013. SIRT6 regulates TNF-a secretion through hydrolysis of long-chain fatty acyl lysine. Nature 496: 110-113.
101. Pisetsky, D. S., H. Erlandsson-Harris, and U. Andersson. 2008. High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease. Arthritis Res. Ther. 10: 209.
102. Gallucci, S., and P. Matzinger. 2001. Danger signals: SOS to the immune system. Curr. Opin. Immunol. 13: 114-119.
103. Richmond, J., M. Tuzova, W. Cruikshank, and D. Center. 2014. Regulation of cellular processes by interleukin-16 in homeostasis and cancer. J. Cell. Physiol. 229: 139-147.
104. Yellapa, A., P. Bitterman, S. Sharma, A. S. Guirguis, J. M. Bahr, S. Basu, J. S. Abramowicz, and A. Barua. 2014. Interleukin 16 expression changes in association with ovarian malignant transformation. Am. J. Obstet. Gynecol. 210: 272.e1-272.e10.
105. Murota, A., K. Suzuki, Y. Kassai, T. Miyazaki, R. Morita, Y. Kondo, M. Takeshita, Y. Niki, A. Yoshimura, and T. Takeuchi. 2016. Serum proteomic analysis identifies interleukin 16 as a biomarker for clinical response during early treatment of rheumatoid arthritis. Cytokine 78: 87-93.
106. Jabri, B., and V. Abadie. 2015. IL-15 functions as a danger signal to regulate tissue-resident T cells and tissue destruction. Nat. Rev. Immunol. 15: 771-783.
107. Kudinova, A. Y., T. Deak, C. M. Hueston, J. E. McGeary, V. S. Knopik, R. H. Palmer, and B. E. Gibb. 2016. Cross-species evidence for the role of interleukin-33 in depression risk. J. Abnorm. Psychol. 125: 482-494.
108. Maes, M., E. Bosmans, R. De Jongh, G. Kenis, E. Vandoolaeghe, and H. Neels. 1997. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 9: 853-858.
109. Maes, M., C. Song, and R. Yirmiya. 2012. Targeting IL-1 in depression. Expert Opin. Ther. Targets 16: 1097-1112.
110. Wu, M. K., T. L. Huang, K. W. Huang, Y. L. Huang, and Y. Y. Hung. 2015. Association between toll-like receptor 4 expression and symptoms of major depressive disorder. Neuropsychiatr. Dis. Treat. 11: 1853-1857.
111. Frank, M. G., M. D. Weber, L. R. Watkins, and S. F. Maier. 2015. Stress sounds the alarmin: the role of the danger-associated molecular pattern HMGB1 in stressinduced neuroinflammatory priming. Brain Behav. Immun. 48: 1-7.
112. Grimaldi, L. M., V. M. Casadei, C. Ferri, F. Veglia, F. Licastro, G. Annoni, I. Biunno, G. De Bellis, S. Sorbi, C. Mariani, et al. 2000. Association of earlyonset Alzheimer's disease with an interleukin-1alpha gene polymorphism. Ann. Neurol. 47: 361-365.
113. Fu, A. K., K. W. Hung, M. Y. Yuen, X. Zhou, D. S. Mak, I. C. Chan, T. H. Cheung, B. Zhang, W. Y. Fu, F. Y. Liew, and N. Y. Ip. 2016. IL-33 ameliorates Alzheimer's disease-like pathology and cognitive decline. Proc. Natl. Acad. Sci. USA 113: E2705-E2713.
114. Karatas, H., S. E. Erdener, Y. Gursoy-Ozdemir, S. Lule, E. Eren-Koçak, Z. D. Sen, and T. Dalkara. 2013. Spreading depression triggers headache by activating neuronal Panx1 channels. Science 339: 1092-1095.